Redwood Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $920K | Buy |
32,748
+224
| +0.7% | +$5.96K | 0.11% | 171 |
|
|
2025
Q4 | $810K | Sell |
32,524
-26,144
| -45% | -$659K | 0.09% | 208 |
|
|
2025
Q3 | $1.5M | Sell |
58,668
-23,379
| -28% | -$577K | 0.16% | 89 |
|
|
2025
Q2 | $1.99M | Buy |
82,047
+6,898
| +9% | +$161K | 0.21% | 81 |
|
|
2025
Q1 | $1.9M | Buy |
75,149
+15,482
| +26% | +$405K | 0.21% | 85 |
|
|
2024
Q4 | $1.58M | Sell |
59,667
-11,876
| -17% | -$322K | 0.15% | 150 |
|
|
2024
Q3 | $2.08M | Sell |
71,543
-3,171
| -4% | -$92.5K | 0.18% | 109 |
|
|
2024
Q2 | $2.09M | Sell |
74,714
-7,041
| -9% | -$194K | 0.18% | 122 |
|
|
2024
Q1 | $2.27M | Buy |
81,755
+503
| +0.6% | +$14K | 0.22% | 104 |
|
|
2023
Q4 | $2.34M | Buy |
81,252
+1,465
| +2% | +$44.3K | 0.21% | 101 |
|
|
2023
Q3 | $2.65M | Buy |
79,787
+32,204
| +68% | +$1.14M | 0.23% | 93 |
|
|
2023
Q2 | $1.75M | Sell |
47,583
-22,105
| -32% | -$860K | 0.18% | 131 |
|
|
2023
Q1 | $2.84M | Buy |
69,688
+62,101
| +819% | +$2.68M | 0.31% | 85 |
|
|
2022
Q4 | $389K | Sell |
7,587
-6,447
| -46% | -$309K | 0.05% | 234 |
|
|
2022
Q3 | $614K | Buy |
14,034
+8,814
| +169% | +$428K | 0.13% | 158 |
|
|
2022
Q2 | $274K | Buy |
5,220
+713
| +16% | +$36.3K | 0.05% | 200 |
|
|
2022
Q1 | $233K | Sell |
4,507
-1,254
| -22% | -$65.1K | 0.03% | 249 |
|
|
2021
Q4 | $340K | Sell |
5,761
-32,240
| -85% | -$1.6M | 0.04% | 233 |
|
|
2021
Q3 | $1.63M | Buy |
38,001
+67
| +0.2% | +$2.97K | 0.23% | 96 |
|
|
2021
Q2 | $1.49M | Buy |
37,934
+5,625
| +17% | +$219K | 0.24% | 95 |
|
|
2021
Q1 | $1.17M | Buy |
32,309
+5,630
| +21% | +$200K | 0.22% | 99 |
|
|
2020
Q4 | $982K | Buy |
26,679
+3,431
| +15% | +$126K | 0.16% | 109 |
|
|
2020
Q3 | $809K | Buy |
23,248
+7,377
| +46% | +$259K | 0.2% | 119 |
|
|
2020
Q2 | $492K | Buy |
+15,871
| New | +$539K | 0.14% | 201 |
|
|
2020
Q1 | – | Sell |
-10,906
| Closed | -$405K | – | 232 |
|
|
2019
Q4 | $405K | Sell |
10,906
-19,710
| -64% | -$702K | 0.1% | 206 |
|
|
2019
Q3 | $1.04M | Buy |
30,616
+14,956
| +96% | +$544K | 0.28% | 90 |
|
|
2019
Q2 | $660K | Buy |
15,660
+9,003
| +135% | +$357K | 0.18% | 120 |
|
|
2019
Q1 | $268K | Buy |
+6,657
| New | +$267K | 0.11% | 135 |
|
|
2018
Q4 | – | Sell |
-127,046
| Closed | -$5.31M | – | 103 |
|
|
2018
Q3 | $5.31M | Sell |
127,046
-22,481
| -15% | -$865K | 1.93% | 5 |
|
|
2018
Q2 | $5.15M | Buy |
149,527
+142,976
| +2,183% | +$4.89M | 1.98% | 5 |
|
|
2018
Q1 | $221K | Buy |
+6,551
| New | +$225K | 0.07% | 106 |
|
Other funds holding PFE
VCM
VPM
Redwood Investment Management's PFE Position: Q1 2026 in Review
Redwood Investment Management increased its Pfizer (PFE) stake by 0.69% in Q1 2026, buying an estimated $5.96K and bringing the position to 32,748 shares worth $920K. The position accounts for 0.11% of the portfolio, ranked #171.
Redwood Investment Management first reported a position in PFE in Q1 2018 and has held it in 31 quarters since. The position peaked at $5.31M in Q3 2018. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Redwood Investment Management held 32,748 shares of Pfizer worth $920K as of Q1 2026.
- Redwood Investment Management bought 224 Pfizer shares in Q1 2026, an estimated $5.96K.
- Pfizer made up 0.11% of Redwood Investment Management's portfolio in Q1 2026, its #171 holding.
- Redwood Investment Management first reported a position in Pfizer in Q1 2018 and has held it in 31 quarters since.
- Redwood Investment Management's Pfizer position peaked at $5.31M in Q3 2018.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Redwood Investment Management's 13F filing for Q1 2026, filed 14 May 2026.